Translational Lung Cancer Research
Note: The following journal information is for reference only. Please check the journal website for updated information prior to submission.
Journal Title
Translational Lung Cancer Research
TRANSL LUNG CANCER R
ISSN / eISSN
2226-4477 / 2218-6751
Aims and Scope
Translational Lung Cancer Research(TLCR, Transl Lung Cancer Res, Print ISSN 2218-6751; Online ISSN 2226-4477) is an international, peer-reviewed, open-access journal, which was founded in March 2012. TLCR is indexed by PubMed/PubMed Central and the Chemical Abstracts Service (CAS) Databases. It is published quarterly the first year, and published bimonthly since February 2013. It provides practical up-to-date information on prevention, early detection, diagnosis, and treatment of lung cancer. Specific areas of its interest include, but not limited to, multimodality therapy, markers, imaging, tumor biology, pathology, chemoprevention, and technical advances related to lung cancer.
Subject Area
ONCOLOGY
RESPIRATORY SYSTEM
CiteScore
5.90
View Trend
CiteScore Ranking
| Category | Quartile | Rank |
|---|---|---|
| Medicine - Oncology | Q2 | #130/366 |
Web of Science Core Collection
| Science Citation Index Expanded (SCIE) | Social Sciences Citation Index (SSCI) |
|---|---|
| Indexed | - |
| Category (Journal Citation Reports 2023) | Quartile |
|---|---|
| ONCOLOGY - SCIE | Q2 |
| RESPIRATORY SYSTEM - SCIE | Q2 |
Country/Area of Publication
Hong Kong
Publisher
Society for Translational Medicine (STM)
Publication Frequency
monthly
Year Publication Started
2012
Annual Article Volume
185
Open Access
YES
Contact
Flat/RM C 16F, Kings Wing Plaza 1, NO. 3 on Kwan Street, Shatin, NT, Hong Kong, China.
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started